Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Ned Tijdschr Geneeskd ; 161: D873, 2017.
Article in Dutch | MEDLINE | ID: mdl-28198345

ABSTRACT

A 27-year-old female was seen with exophytic protrusions on the vaginal wall. Biopsy showed a squamous papilloma. This benign tumour is an expression of a non-oncogenic human papillomavirus infection. Although treatment is not necessary, screening for sexual transmitted diseases is advised.


Subject(s)
Papillomavirus Infections/diagnosis , Sexually Transmitted Diseases, Viral/diagnosis , Tumor Virus Infections/diagnosis , Adult , Female , Humans , Papillomaviridae , Vagina
2.
J Obstet Gynaecol ; 34(2): 117-22, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24456429

ABSTRACT

BACKGROUND: Fetal/neonatal hyperthyroidism is a well-known complication of maternal Graves' disease with high concentrations of TSH-receptor antibodies (TRAb). Few data are available on the management of fetal hyperthyroidism in surgically treated Graves' disease. METHODS: Clinical, ultrasound and biochemical data are reported in a fetus/neonate whose mother underwent a thyroidectomy > 10 years before and whose sibling was thin and hyperthyroid at birth. RESULTS: Maternal TRAb were persistently > 40 U/l; unequivocal signs of fetal hyperthyroidism were identified at 29 weeks gestational age (GA). The fetus was treated through maternal antithyroid drug (ATD) administration; the dose was reduced gradually once fetal tachycardia and valve dysfunction disappeared and normal T4 was confirmed by fetal blood sampling. Maternal euthyroidism was maintained. The neonate showed normal growth for GA and T4 concentration at birth but severe hyperthyroidism relapsed from day 13 until day 58. TSH remained strongly suppressed throughout the pre- and postnatal course. CONCLUSIONS: Prenatal ATD in a taper-off regime allowed normal T4 and growth in a hyperthyroid fetus from a thyroidectomised Graves' mother. Fetal TSH cannot be used to adjust the ATD dose. Prenatal ATD appears to postpone the onset but does not affect the severity or duration of the neonatal hyperthyroid flare.


Subject(s)
Fetal Diseases/etiology , Graves Disease/surgery , Hyperthyroidism/congenital , Adolescent , Adult , Antithyroid Agents/therapeutic use , Female , Fetal Diseases/drug therapy , Humans , Hyperthyroidism/drug therapy , Infant, Newborn , Male , Pregnancy , Thyroidectomy
3.
Ultrasound Obstet Gynecol ; 40(6): 706-13, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22407678

ABSTRACT

OBJECTIVES: To describe clinical and ultrasound features of Brenner tumors of the ovary. METHODS: In this retrospective study, the databases of the International Ovarian Tumor Analysis (IOTA) studies and one tertiary center were searched to identify patients who had undergone an ultrasound scan before surgery for an adnexal mass that proved to be a Brenner tumor. Twenty-eight patients with 29 Brenner tumors were included, most of which had been collected within the framework of the IOTA studies. An experienced ultrasound examiner reviewed available ultrasound images (available for 14 tumors), searching for a pattern specific to Brenner tumors. RESULTS: Most patients were postmenopausal and asymptomatic. Twenty-four (83%) tumors were benign, two (7%) were borderline and three (10%) were malignant. Most benign tumors (17/24, 71%) contained solid components and manifested no or minimal blood flow on Doppler examination (19/24, 79%). Information about calcifications was available for 15 benign tumors, and in 13 (87%) calcifications were present. The five borderline and invasively malignant tumors contained solid components less often than did the benign ones (3/5, 60%) and were more richly vascularized on Doppler examination. Information about calcifications was available for four borderline or invasively malignant tumors, and in three (75%) calcifications were present. CONCLUSION: We failed to demonstrate ultrasound features specific to Brenner tumors. A prospective study is needed to determine if ultrasound features of calcifications can discriminate between Brenner tumors and other types of ovarian tumor.


Subject(s)
Brenner Tumor/diagnostic imaging , Ovarian Neoplasms/diagnostic imaging , Adult , Aged , Aged, 80 and over , Brenner Tumor/pathology , Brenner Tumor/surgery , Female , Humans , Middle Aged , Ovarian Neoplasms/pathology , Ovarian Neoplasms/surgery , Preoperative Care/methods , Prognosis , Retrospective Studies , Tumor Burden , Ultrasonography, Doppler, Color
4.
Eur J Obstet Gynecol Reprod Biol ; 158(2): 153-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21741751

ABSTRACT

The treatment of mid-gestational uterine incarceration remains a challenge. The success rate of manual reduction decreases with gestational age, and an operative procedure may carry important fetal, next to possible maternal morbidities. We will present four cases of uterine incarceration between the 15th and 25th week of pregnancy of which three colonoscopy-assisted manual repositions proved successful. It illustrates that conservative treatment of uterine incarceration is feasible, even during the late second trimester. That is why a review of the conservative approach of this rare condition is also presented.


Subject(s)
Uterine Retroversion/therapy , Adult , Colonoscopy , Female , Humans , Pregnancy
5.
Gynecol Obstet Invest ; 70(3): 186-91, 2010.
Article in English | MEDLINE | ID: mdl-20558993

ABSTRACT

A 50-year-old female complained of a painless abdominal distension. Histopathologic examination after cystectomy showed a primary poorly differentiated retroperitoneal mucinous cystadenocarcinoma with a sarcoma-like mural nodule. The patient subsequently underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy, appendectomy, omentectomy and lymphadenectomy. Adjuvant chemotherapy consisted of 6 times carboplatin (AUC 7) in monotherapy (every 4 weeks). Based on 49 cases of primary retroperitoneal mucinous cystadenocarcinoma, we discuss the histogenesis and we define the appropriate treatment.


Subject(s)
Cystadenocarcinoma, Mucinous/pathology , Retroperitoneal Neoplasms/pathology , Antineoplastic Agents/therapeutic use , Appendectomy , Carboplatin/therapeutic use , Chemotherapy, Adjuvant , Cystadenocarcinoma, Mucinous/drug therapy , Cystadenocarcinoma, Mucinous/surgery , Female , Humans , Hysterectomy , Lymph Node Excision , Middle Aged , Omentum/surgery , Ovariectomy , Pelvis/surgery , Retroperitoneal Neoplasms/drug therapy , Retroperitoneal Neoplasms/surgery , Salpingectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...